Literature DB >> 17565497

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".

Glenn Flux, Manuel Bardies, Carlo Chiesa, Myriam Monsieurs, Sauli Savolainen, Sven-Erik Strand, Michael Lassmann.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17565497     DOI： 10.1007/s00259-007-0471-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  7 in total

1.  Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid.

Authors:  S M SEIDLIN; L D MARINELLI; E OSHRY
Journal:  J Am Med Assoc       Date:  1946-12-07

2.  Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

Authors:  G A Wiseman; C A White; R B Sparks; W D Erwin; D A Podoloff; D Lamonica; N L Bartlett; J A Parker; W L Dunn; S M Spies; R Belanger; T E Witzig; B R Leigh
Journal:  Crit Rev Oncol Hematol       Date:  2001 Jul-Aug       Impact factor: 6.312

3.  Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.

Authors:  K K Matthay; C Panina; J Huberty; D Price; D V Glidden; H R Tang; R A Hawkins; J Veatch; B Hasegawa
Journal:  J Nucl Med       Date:  2001-11       Impact factor: 10.057

4.  Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.

Authors:  Heribert Hänscheid; Michael Lassmann; Markus Luster; Stephen R Thomas; Furio Pacini; Claudia Ceccarelli; Paul W Ladenson; Richard L Wahl; Martin Schlumberger; Marcel Ricard; Al Driedger; Richard T Kloos; Steven I Sherman; Bryan R Haugen; Vincent Carriere; Carine Corone; Christoph Reiners
Journal:  J Nucl Med       Date:  2006-04       Impact factor: 10.057

5.  The European Directive on health protection of individuals against the dangers of ionising radiation in relation to medical exposures (97/43/EURATOM).

Authors:  D Teunen
Journal:  J Radiol Prot       Date:  1998-06       Impact factor: 1.394

6.  Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.

Authors:  George Sgouros; Katherine S Kolbert; Arif Sheikh; Keith S Pentlow; Edward F Mun; Axel Barth; Richard J Robbins; Steven M Larson
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

Review 7.  Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".

Authors:  B Brans; L Bodei; F Giammarile; O Linden; M Luster; W J G Oyen; J Tennvall
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05       Impact factor: 9.236
  7 in total
  11 in total

1.  Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.

Authors:  Renaud Lhommel; Larry van Elmbt; Pierre Goffette; Marc Van den Eynde; François Jamar; Stanislas Pauwels; Stephan Walrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-27       Impact factor: 9.236

2.  Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09       Impact factor: 9.236

3.  Comment on long-term risk in radioiodine treatment of hyperthyroidism.

Authors:  Agata Baldys-Waligorska; Alicja Hubalewska-Dydejczyk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09       Impact factor: 9.236

Review 4.  Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.

Authors:  Massimo Salvatori; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04       Impact factor: 9.236

5.  Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts.

Authors:  Stephan Walrand; Raffaella Barone; Stanislas Pauwels; François Jamar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-12       Impact factor: 9.236

6.  Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

Authors:  Arnaud Dieudonné; Robert F Hobbs; Rachida Lebtahi; Fabien Maurel; Sébastien Baechler; Richard L Wahl; Ariane Boubaker; Dominique Le Guludec; Georges Sgouros; Isabelle Gardin
Journal:  J Nucl Med       Date:  2012-12-18       Impact factor: 10.057

Review 7.  The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy.

Authors:  Lidia Strigari; Mark Konijnenberg; Carlo Chiesa; Manuel Bardies; Yong Du; Katarina Sjögreen Gleisner; Michael Lassmann; Glenn Flux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-11       Impact factor: 9.236

8.  Comparison of Accuracy in Calculation of Absorbed Dose to Patients Following Bone Scan with (99m)Tc-Marked Diphosphonates by Two Different Background Correction Methods.

Authors:  Daryoush Shahbazi-Gahrouei; Mehri Damoori; Mohammad Bagher Tavakoli; Masoud Moslehi
Journal:  J Med Signals Sens       Date:  2016 Jan-Mar

Review 9.  Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.

Authors:  Massimiliano Pacilio; Miriam Conte; Viviana Frantellizzi; Maria Silvia De Feo; Antonio Rosario Pisani; Andrea Marongiu; Susanna Nuvoli; Giuseppe Rubini; Angela Spanu; Giuseppe De Vincentis
Journal:  Diagnostics (Basel)       Date:  2022-07-21

Review 10.  The physics of radioembolization.

Authors:  Remco Bastiaannet; S Cheenu Kappadath; Britt Kunnen; Arthur J A T Braat; Marnix G E H Lam; Hugo W A M de Jong
Journal:  EJNMMI Phys       Date:  2018-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.